Cotinga Pharmaceuticals Inc COTQF

Stern IR advising them

[XRRH2008]

This is the guy that's advising COT. Matthew Shinseki at Stern IR. I've emailed him but haven't heard back yet. His email adress is [e-mail] if you're interested.

[DIYGuy]

Honestly, if you have been around this stock awhile you already know everything he will tell you. The company will release the cohort information in a press release when they have material news. They can only advise on the dose promotion when it occurs. Nothing else. In his defence I would be concerned if they told you more than the street knows. Also, the share consolidation was done to attract

[XRRH2008]

The consolidation was an amateurish move. Having a share price over $1 does not attract institutional investors when your market cap is under $20million. What a joke. These funds have minimum valuations they look at -  normally a minimum market capitalization of $100 million or more.

[fatladysings321]

I have to say, Alison is also a coward to tell investors to start directing their question to some IR firm. Stock at about the equivalent of 10 cents a share. Have a wonderful weekend. Thanks,

[DIYGuy]

Maybe the reverse split should have been 50:1. Next stop super cheap financing or it's over. Great job PR firms. Could you be more useless? And that Boston office. Why?